-
Mashup Score: 14Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients - 11 hour(s) ago
To systematically study the association of monoclonal gammopathy of undetermined significance (MGUS) with all diseases in a population-based cohort of 17,398 patients, all of whom were uniformly tested for the presence or absence of MGUS.
Source: www.mayoclinicproceedings.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7“Not Medically Necessary”: Inside the Company Helping America’s Biggest Health Insurers Deny Coverage for Care - 14 day(s) ago
When companies like Aetna or UnitedHealthcare want to rein in costs, they turn to EviCore, whose business model depends on turning down payments for care recommended by doctors for their patients.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet-
While on topic of whether you can be sure you will get healthcare coverage when you need it… https://t.co/qc5WPzcId8 @propublica @txtianmiller @DavidArmstrongX @Capitol_Forum @PatrickMRucker
-
-
Mashup Score: 7“Not Medically Necessary”: Inside the Company Helping America’s Biggest Health Insurers Deny Coverage for Care - 14 day(s) ago
When companies like Aetna or UnitedHealthcare want to rein in costs, they turn to EviCore, whose business model depends on turning down payments for care recommended by doctors for their patients.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet-
While on topic of whether you can be sure you will get healthcare coverage when you need it… https://t.co/qc5WPzcId8 @propublica @txtianmiller @DavidArmstrongX @Capitol_Forum @PatrickMRucker
-
-
Mashup Score: 10
Blood Cancer Journal – Mode of progression in smoldering multiple myeloma: a study of 406 patients
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Similar findings in an earlier study published by our group. @BloodCancerJnl @nadineabdal @MayoMyeloma Mode of progression in smoldering multiple myeloma: a study of 406 patients https://t.co/jqxQUfFurH
-
-
Mashup Score: 63Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma - 17 day(s) ago
Blood Cancer Journal – Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
Bone lesions are the mode of progression in ~30% of patients with high risk smoldering myeloma. Pattern of progression in smoldering myeloma in 447 patients. @EliasKarlMai @RaabMarc @VisramAlissa @BloodCancerJnl https://t.co/liMKt9KSWB
-
-
Mashup Score: 15Additional price cuts to insulin are on the way - - 19 day(s) ago
Over the past couple of weeks, a lot has happened within the insulin drug class. It started on March 1, when Eli Lilly announced price reductions of 70% on its commonly prescribed insulins and an expansion of its Insulin Value Program that caps out-of-pocket costs at $35 per month. Then, last week, Novo Nordisk and […]
Source: abarcahealth.comCategories: General Medicine News, Hem/OncsTweet-
Great table on the decrease in insulin prices that happened Jan 1 this year. @AbarcaHealth https://t.co/26kupRMTLI Advocacy works. https://t.co/9SAdKyyF7n
-
-
Mashup Score: 7The High Cost of Cancer Drugs and What We Can Do About It - 19 day(s) ago
Last year, ipilimumab (Yervoy; Bristol-Myers Squibb, New York, NY) was approved by the Food and Drug Administration (FDA) for the treatment of metastatic melanoma. The benefit in survival over and above standard treatment arms was 3.7 months in previously treated patients and 2.1 months in previously untreated patients.1,2 The cost: $120,000 for 4 doses. As staggering a figure as that is, the drug is hardly alone in its lofty price. We believe that the immense cost of contemporary cancer drugs signals even greater costs for future drugs (Table).
Source: www.mayoclinicproceedings.orgCategories: General Medicine News, Hem/OncsTweet-
Read more here in the paper we wrote in 2012. https://t.co/rcZNgIuM1m
-
-
Mashup Score: 104Homepage of Mark Cuban Cost Plus Drugs - 20 day(s) ago
Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.
Source: costplusdrugs.comCategories: General Medicine News, Hem/OncsTweet-
My year end endorsements. 1) @costplusdrugs — where you can get >2000 prescription meds at lower price than almost any other pharmacy in America. Has revolutionized the generic prescription drug market. @mcuban https://t.co/QmT2Ta9kma https://t.co/BbVBZu2Grg
-
-
Mashup Score: 8“Not Medically Necessary”: Inside the Company Helping America’s Biggest Health Insurers Deny Coverage for Care - 25 day(s) ago
When companies like Aetna or UnitedHealthcare want to rein in costs, they turn to EviCore, whose business model depends on turning down payments for care recommended by doctors for their patients.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet-
While on topic of whether you can be sure you will get healthcare coverage when you need it… https://t.co/qc5WPzcId8 @propublica @txtianmiller @DavidArmstrongX @Capitol_Forum @PatrickMRucker
-
-
Mashup Score: 8“Not Medically Necessary”: Inside the Company Helping America’s Biggest Health Insurers Deny Coverage for Care - 26 day(s) ago
When companies like Aetna or UnitedHealthcare want to rein in costs, they turn to EviCore, whose business model depends on turning down payments for care recommended by doctors for their patients.
Source: www.propublica.orgCategories: General Medicine News, Hem/OncsTweet-
While on topic of whether you can be sure you will get healthcare coverage when you need it… https://t.co/qc5WPzcId8 @propublica @txtianmiller @DavidArmstrongX @Capitol_Forum @PatrickMRucker
-
@sykristinsson This is similar to our disease association study from Olmsted County where we found most “disease associations” with MGUS are coincidental. @MayoProceedings https://t.co/cV6JSC9dST